Gene: SEC31B
Official Full Name: SEC31 homolog B, COPII coat complex componentprovided by HGNC
Gene Summary: This gene encodes a protein of unknown function. The protein has moderate similarity to rat VAP1 protein which is an endosomal membrane-associated protein, containing a putative Ca2+/calmodulin-dependent kinase II phosphorylation site. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28562 | SEC31B Knockout cell line (HeLa) | Human | SEC31B | 1:3~1:6 | Negative | Online Inquiry |
KO28563 | SEC31B Knockout cell line (HCT 116) | Human | SEC31B | 1:2~1:4 | Negative | Online Inquiry |
KO28564 | SEC31B Knockout cell line (A549) | Human | SEC31B | 1:3~1:4 | Negative | Online Inquiry |
SEC31B Gene Knockout Cell Lines are engineered cellular platforms designed to facilitate the study of the SEC31B gene, which is critical for the formation and function of COPII vesicles during intracellular transport processes. By systematically disrupting the expression of SEC31B through targeted knockout technology, these cell lines provide researchers with a potent tool to investigate the molecular mechanisms underlying protein secretion and vesicular trafficking.
The primary function of the SEC31B gene lies in its role as a structural component of the coat protein complex II (COPII), which is essential for the transport of proteins from the endoplasmic reticulum to the Golgi apparatus. The genetically modified cell lines allow for the elucidation of the disruptions caused by SEC31B loss, enabling scientists to explore its implications in various cellular processes and disease states, including metabolic disorders and neurodegenerative diseases.
The scientific importance of SEC31B Gene Knockout Cell Lines is underscored by their applicability in both fundamental research and clinical settings. They serve as invaluable models for drug discovery, as researchers can use these lines to screen pharmaceutical compounds aimed at restoring proper vesicular transport mechanisms. Furthermore, they open avenues for investigating disease mechanisms linked to protein misfolding and aggregation.
Key advantages of these knockout cell lines include their precise genetic modification, which ensures high specificity and reproducibility in experiments. Unlike alternative platforms, such as transient knockdown approaches, SEC31B Gene Knockout Cell Lines provide stable and persistent gene disruption, thereby offering researchers consistent data over time.
For researchers and clinicians alike, the value of SEC31B Gene Knockout Cell Lines is evident in their capacity to deepen the understanding of intracellular trafficking and its broader implications in health and disease. With superior reliability and extensive support for experimental applications, our products stand at the forefront of biological research. Our company is dedicated to empowering scientific discovery by providing high-quality genetic tools and resources to advance the study of cellular mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.